The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth

Cancer Letters

Volumn 343, Issue 1, 2014, Pages 51-61

  Zhu, Hu ^a   Carpenter, Richard L ^a   Han, Woody ^a   Lo, Hui Wen ^a,b,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Cancer; GLI1; Hedgehog pathway; Transcriptional regulation

Indexed keywords

HEPARANASE; ONCOPROTEIN; SMALL INTERFERING RNA; TRUNCATED GLIOMA ASSOCIATED ONCOGENE HOMOLOG 1 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE GLI1; ONCOGENE TGLI1; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION;

ERINACEIDAE;

EID: 84890856371     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.09.014     Document Type: Article

References (52)

1. Echelard Y., Epstein D.J., St-Jacques B., Shen L., Mohler J., McMahon J.A., McMahon A.P. Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity. Cell 1993, 75:1417-1430.
2. Roelink H., Augsburger A., Heemskerk J., Korzh V., Norlin S., Ruiz i Altaba A., Tanabe Y., Placzek M., Edlund T., Jessell T.M., et al. Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord. Cell 1994, 76:761-775.
3. Dahmane N., Sanchez P., Gitton Y., Palma V., Sun T., Beyna M., Weiner H., Ruiz i Altaba A. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development (Cambridge, England) 2001, 128:5201-5212.
4. Rao G., Pedone C.A., Del Valle L., Reiss K., Holland E.C., Fults D.W. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 2004, 23:6156-6162.
5. Chen B.Y., Liu J.Y., Chang H.H., Chang C.P., Lo W.Y., Kuo W.H., Yang C.R., Lin D.P. Hedgehog is involved in prostate basal cell hyperplasia formation and its progressing towards tumorigenesis. Biochemical and biophysical research communications 2007, 357:1084-1089.
6. Feldmann G., Fendrich V., McGovern K., Bedja D., Bisht S., Alvarez H., Koorstra J.B., Habbe N., Karikari C., Mullendore M., Gabrielson K.L., Sharma R., Matsui W., Maitra A. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Molecular Cancer Therapeutics 2008, 7:2725-2735.
7. R. Carpenter, H.W. Lo, Hedgehog pathway and GLI1 Isoforms in human cancer, Discovery Medicine 13, 2012.
8. Kinzler K.W., Vogelstein B. The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Molecular and Cellular Biology 1990, 10:634-642.
9. Yoon J.W., Gilbertson R., Iannaccone S., Iannaccone P., Walterhouse D. Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes. International Journal of Cancer 2009, 124:109-119.
10. Kinzler K.W., Ruppert J.M., Bigner S.H., Vogelstein B. The GLI gene is a member of the Kruppel family of zinc finger proteins. Nature 1988, 332:371-374.
11. Zhu H., Lo H.-W. The human glioma-associated oncogene homolog 1 (GLI1) family of transcription factors in gene regulation and diseases. Current Genomics 2010, 11:238-245.
12. Kinzler K.W., Bigner S.H., Bigner D.D., Trent J.M., Law M.L., O'Brien S.J., Wong A.J., Vogelstein B. Identification of an amplified, highly expressed gene in a human glioma. Science 1987, 236:70-73. New York, NY.
13. Bigner S.H., Wong A.J., Mark J., Muhlbaier L.H., Kinzler K.W., Vogelstein B., Bigner D.D. Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genetics and Cytogenetics 1987, 29:165-170.
14. Forus A., Florenes V.A., Maelandsmo G.M., Meltzer P.S., Fodstad O., Myklebost O. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth & Differentiation 1993, 4:1065-1070.
15. Wong A.J., Bigner S.H., Bigner D.D., Kinzler K.W., Hamilton S.R., Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:6899-6903.
16. Shimokawa T., Tostar U., Lauth M., Palaniswamy R., Kasper M., Toftgard R., Zaphiropoulos P.G. Novel human glioma-associated oncogene 1 (GLI1) splice variants reveal distinct mechanisms in the terminal transduction of the hedgehog signal. The Journal of biological chemistry 2008, 283:14345-14354.
17. Lo H.W., Zhu H., Cao X., Aldrich A., Ali-Osman F. A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion. Cancer Research 2009, 69:6790-6798.
18. Cao X., Geradts J., Dewhirst M.W., Lo H.W. Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene 2012, 31:104-115.
19. Han W., Carpenter R.L., Lo H.-W. TGLI1 upregulates expression of VEGFR2 and VEGF-A, leading to a robust VEGF-VEGFR2 autocrine loop and cancer cell growth. Cancer Hallmarks 2013, 1:28-37.
20. Chen T.C., Wang W., Golden E.B., Thomas S., Sivakumar W., Hofman F.M., Louie S.G., Schonthal A.H. Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models. Cancer Letters 2011, 302:100-108.
21. Hodgson J.G., Yeh R.F., Ray A., Wang N.J., Smirnov I., Yu M., Hariono S., Silber J., Feiler H.S., Gray J.W., Spellman P.T., Vandenberg S.R., Berger M.S., James C.D. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. Neuro-oncology 2009, 11:477-487.
22. Du R., Lu K.V., Petritsch C., Liu P., Ganss R., Passegue E., Song H., Vandenberg S., Johnson R.S., Werb Z., Bergers G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008, 13:206-220.
23. Lo H.W., Cao X., Zhu H., Ali-Osman F. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators. Clinical Cancer Research 2008, 14:6042-6054.
24. Zhu H., Cao X., Ali-Osman F., Keir S., Lo H.-W. EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity. Cancer Letters 2010, 294:101-110.
25. Lee J., Lund-Smith C., Borboa A., Gonzalez A.M., Baird A., Eliceiri B.P. Glioma-induced remodeling of the neurovascular unit. Brain research 2009, 1288:125-134.
26. Zetser A., Bashenko Y., Edovitsky E., Levy-Adam F., Vlodavsky I., Ilan N. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Research 2006, 66:1455-1463.
27. Vlodavsky I., Goldshmidt O., Zcharia E., Atzmon R., Rangini-Guatta Z., Elkin M., Peretz T., Friedmann Y. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Seminars in Cancer Biology 2002, 12:121-129.
28. Vreys V., David G. Mammalian heparanase: what is the message?. Journal of cellular and molecular medicine 2007, 11:427-452.
29. Olsson A.K., Dimberg A., Kreuger J., Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nature Reviews Molecular Cell Biology 2006, 7:359-371.
30. Zhang Y., Zhang N., Dai B., Liu M., Sawaya R., Xie K., Huang S. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Research 2008, 68:8733-8742.
31. Anderson J.C., McFarland B.C., Gladson C.L. New molecular targets in angiogenic vessels of glioblastoma tumours. Expert reviews in molecular medicine 2008, 10:e23.
32. Bello L., Giussani C., Carrabba G., Pluderi M., Costa F., Bikfalvi A. Angiogenesis and invasion in gliomas. Cancer Treatment and Research 2004, 117:263-284.
33. Kanda S., Mochizuki Y., Suematsu T., Miyata Y., Nomata K., Kanetake H. Sonic hedgehog induces capillary morphogenesis by endothelial cells through phosphoinositide 3-kinase. The Journal of Biological Chemistry 2003, 278:8244-8249.
34. Nagase T., Nagase M., Machida M., Fujita T. Hedgehog signalling in vascular development. Angiogenesis 2008, 11:71-77.
35. Chinchilla P., Xiao L., Kazanietz M.G., Riobo N.A. Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways. Cell Cycle 2010, 9:570-579.
36. L.G. Harris, L.K. Pannell, S. Singh, R.S. Samant, L.A. Shevde, Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61, Oncogene, 2011.
37. Bigner S.H., Humphrey P.A., Wong A.J., Vogelstein B., Mark J., Friedman H.S., Bigner D.D. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Research 1990, 50:8017-8022.
38. Lakka S.S., Rao J.S. Antiangiogenic therapy in brain tumors. Expert Review of Neurotherapeutics 2008, 8:1457-1473.
39. Friedman H.S., Prados M.D., Wen P.Y., Mikkelsen T., Schiff D., Abrey L.E., Yung W.K., Paleologos N., Nicholas M.K., Jensen R., Vredenburgh J., Huang J., Zheng M., Cloughesy T. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. Journal of Clinical Oncology 2009, 27:4733-4740.
40. Sathornsumetee S., Desjardins A., Vredenburgh J.J., McLendon R.E., Marcello J., Herndon J.E., Mathe A., Hamilton M., Rich J.N., Norfleet J.A., Gururangan S., Friedman H.S., Reardon D.A. Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma. Neuro Oncol 2010, 12:1300-1310.
41. Reardon D.A., Desjardins A., Vredenburgh J.J., Gururangan S., Friedman A.H., Herndon J.E., Marcello J., Norfleet J.A., McLendon R.E., Sampson J.H., Friedman H.S. Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma. Journal of Neuro-oncology 2010, 96:219-230.
42. Charafe-Jauffret E., Ginestier C., Birnbaum D. Breast cancer stem cells: tools and models to rely on. BMC cancer 2009, 9:202.
43. Merchant A., Joseph G., Wang Q., Brennan S., Matsui W. Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood 2010, 115:2391-2396.
44. Chang H.H., Chen B.Y., Wu C.Y., Tsao Z.J., Chen Y.Y., Chang C.P., Yang C.R., Lin D.P. Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse model. Journal of Biomedical Science 2011, 18:6.
45. Zaphiropoulos P. Genetic variations and alternative splicing. The Glioma associated oncogene 1, GLI1. Frontiers in Genetics 2012, 3.
46. Stecca B., Mas C., Clement V., Zbinden M., Correa R., Piguet V., Beermann F., Ruiz I.A.A. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:5895-5900.
47. Ji Z., Mei F.C., Xie J., Cheng X. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells. The Journal of Biological Chemistry 2007, 282:14048-14055.
48. Fan Q., He M., Sheng T., Zhang X., Sinha M., Luxon B., Zhao X., Xie J. Requirement of TGFbeta signaling for SMO-mediated carcinogenesis. The Journal of Biological Chemistry 2010, 285:36570-36576.
49. Sheng T., Chi S., Zhang X., Xie J. Regulation of Gli1 localization by the cAMP/protein kinase A signaling axis through a site near the nuclear localization signal. The Journal of Biological Chemistry 2006, 281:9-12.
50. Cai Q., Li J., Gao T., Xie J., Evers B.M. Protein kinase Cdelta negatively regulates hedgehog signaling by inhibition of Gli1 activity. The Journal of Biological Chemistry 2009, 284:2150-2158.
51. Klopp A.H., Lacerda L., Gupta A., Debeb B.G., Solley T., Li L., Spaeth E., Xu W., Zhang X., Lewis M.T., Reuben J.M., Krishnamurthy S., Ferrari M., Gaspar R., Buchholz T.A., Cristofanilli M., Marini F., Andreeff M., Woodward W.A. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS ONE 2010, 5:e12180.
52. Stecca B., Ruiz i Altaba A. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J 2009, 28:663-676.